Tag archive for ‘David Pyott’
Vered Weiss On Thursday, February 12th, 2015

Allergan CEO Says Fighting Off Activist Bill Ackman Was Full Time Job

One thing Allergan CEO David Pyott enjoyed doing was running his company. When activist investor Bill Ackman of Pershing Square decided to have Valeant Pharmaceuticals try to swallow up the Botox maker in a More...

Vered Weiss On Tuesday, January 20th, 2015

Nelson Peltz Makes Truce with Pepsi, But Still May Break Up DuPont

After months of fighting tooth and nail to convince PepsiCo that it should split its beverage from its snacks division, Nelson Peltz of Trian Management and Pepsico CEO Indra Nooyi seem to have made a truce, More...

Vered Weiss On Wednesday, January 7th, 2015

Alpha Wolf Bill Ackman Is Top Dog on Wall Street

Bill Ackman might be controversial, but he had the top performing hedge fund of 2014, as reported by Bloomberg. While he was ridiculed the previous year for his pressure to put Ron Johnson of AppleStores as More...

Vered Weiss On Tuesday, December 30th, 2014

Is Bill Ackman Guilty of Insider Trading?

Bill Ackman has cleaned up this year to the tune of $1 billion. He has also profited from Actavis’ announced merger with Botox maker Allergan, although for many months, he was pushing the company to accept More...

Tibi Singer On Wednesday, November 26th, 2014

Actavis Saves Allergan from Valeant Hostile Takeover with $66 Billion Deal, But Will Slash R&D

The seven-month battle over American Botox haven pharmaceutical company Allergan is over, after it accepted a friendly takeover bid from Irish integrated specialty pharmaceutical Actavis. The Actavis offer More...

Vered Weiss On Thursday, November 20th, 2014

Bill Ackman Finally Throws in the Towel with Allergan Shareholders’ Meeting

After an intense and acrimonious months long battle for a hostile takeover of Allergan, Bill Ackman, who owns a 9.7% stake in the company, finally gave up his battle to convene a special shareholders’ More...

Vered Weiss On Tuesday, October 28th, 2014

Allergan Still Doing Fine, Thank You Very Much, Without Valeant, Ackman

In the ongoing hostile pursuit to take over Allergan, major shareholder in the company, Bill Ackman and Valeant just don’t seem ready to quit, even though the company has been doing quite well, thank you, More...

Vered Weiss On Wednesday, October 8th, 2014

Actavis Joins In the Battle for Botox, Valeant Raises Its Bid

–   With the hostile takeover saga of Botox-maker Allergan raging on for months, the situation has become even more complicated, with Actavis jumping with a bid for Allergan, as reported by Reuters. More...

Vered Weiss On Monday, September 8th, 2014

Does Bill Ackman Need Botox More Than Botox Needs Ackman?

Looking youthful for his mid-forties, Bill Ackman doesn’t seem to need Botox. So why is he so hot on the trail for Allergan, encouraging the Botox maker to acquiesce to Valeant’s hostile takeover More...

Vered Weiss On Friday, September 5th, 2014

John Paulson Adds Battleground Stock Allergan

Fund manager John Paulson added a new position in controversial stock Allergan, which is the object of a hostile takeover bid by Valeant Pharmaceuticals. The Allergan position now accounts for 4.11% of Paulson’s More...

Wordpress site Developed by Fixing WordPress Problems